small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search
  • Professionals (566)
  • Capabilities (83)
  • Experience (386)
  • Insights & News (2,745)
  • Other Results (87)

Professionals 566 results

Bradley C. Vaiana
Bradley C. Vaiana
Partner
  • New York
Email
+1 212-294-2610
vCard

Partner

  • New York
David A. Sakowitz
David A. Sakowitz
Partner
  • New York, 
  • London
Email
+1 212-294-2639
vCard

Partner

  • New York
  • London
Matt Stockstill
Matt Stockstill
Partner
  • Dallas
Email
+1 214-453-6449
vCard

Partner

  • Dallas
View All Professionals

Capabilities 83 results

Practice Area

Private Equity

Winston & Strawn’s private equity attorneys provide strategic advice and legal counsel to middle-market private equity funds, hedge funds, family offices, real estate funds, alternative asset managers, portfolio companies, and institutional investors. We have one of the broadest and most active national middle-market private equity practices in the U.S. ...Read more

Practice Area

Capital Markets

Our capital markets and securities attorneys represent U.S. and international issuers, institutional investors, underwriters, and placement agents in a wide variety of public and private offerings of debt and equity securities....Read more

Practice Area

Secondaries & Liquidity Solutions

Winston & Strawn’s Secondaries and Liquidity Solutions group delivers market-leading counsel to clients navigating the evolving landscape of private fund liquidity, secondaries transactions, and bespoke capital solutions. Our multidisciplinary team advises private fund sponsors, institutional investors, and asset managers on the full spectrum of private investment fund secondary market activity, from traditional LP portfolio sales to complex GP-led transactions and innovative liquidity structures. Our attorneys are consistently recognized by leading private equity corporate publications, including Chambers, Legal 500, and others....Read more

Experience 386 results

Experience

|

April 23, 2025

Voyager Acquisition Corp. and VERAXA Biotech Announce Business Combination

Experience

|

April 11, 2025

Cuprina Holdings (Cayman) Limited Announces Closing of Initial Public Offering

Experience

|

April 3, 2025

Winston Paris advised David Vincent, CEO and Co-Founder of smartTrade Technologies, in connection with the entry of TA Associates, into the company’s capital

View All Experience

Insights & News 2,745 results

Sponsorship

|

June 11, 2025

Winston & Strawn Sponsors 2025 Private Company Strategic Alternatives Symposium

Winston is a proud sponsor of the Private Company Strategic Alternatives Symposium on June 11, 2025. This exciting half-day event will bring together leading industry voices to discuss current market trends, capital growth opportunities, and strategies to address liquidity and value creation....Read more

Sponsorship

|

June 5, 2025

Winston & Strawn Sponsors Sidebar Summit Conference

Winston & Strawn is proud to sponsor the Sidebar Summit Conference in New York on June 5, 2025. The conference brings together the brightest minds in technology, entrepreneurship, venture capital, academia, and government....Read more

Sponsorship

|

May 28, 2025

Winston & Strawn Sponsors SBIA’s 2025 Midwest Deal Summit

Winston & Strawn is proud to be an elite sponsor for the Small Business Investor Alliance’s (SBIA) 2025 Midwest Deal Summit on May 28-29, 2025, in Chicago....Read more
View All Insights & News

Other Results 87 results

Law Glossary

What Is Consumer Marketing Law?

Consumer marketing law is a broad legal segment dealing with federal and state statutes, along with government regulations, established to ensure that marketing and advertising are truthful. Federal law states that no form of advertising, including online advertising, can be deceptive. Marketing claims must also be evidence-based....Read more

Law Glossary

What Statutes and Regulations Govern the Approval and Marketing of Biosimilars?

Congress passed the Biologics Price Competition and Innovation Act of 2009 (BPCIA) in 2010 an amendment of the Public Health Services Act. The BPCIA is codified at 42 U.S.C. § 262....Read more

Site Content

What Is an IPO?

An IPO is an initial public offering, in which shares of a private company are made available publicly for the first time, allowing a company to raise equity capital from public investors. Companies must meet specific legal, governance, and accounting requirements imposed by the securities exchanges and the Securities and Exchange Commission (SEC) to conduct an IPO. Companies hire investment banks to market the offering, evaluate investor demand, and set the IPO price....Read more
Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2025. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising